| Literature DB >> 33816392 |
Sheila Haghighat1, Samira Oshaghi1.
Abstract
Temporomandibular disorder is a multifactorial disease that causes pain in the jaw and face area with nondental origin, which frequently limits talking, chewing, and other jaw activities. Various factors such as malocclusion, trauma, stress, parafunctional habits (clenching and bruxing), osteoarthritis, and synovitis play a role in its occurrence, although the etiology of these disorders is little understood. Several treatments are being used to treat these disorders. Ozone therapy has been recently introduced as one of these treatments. Considering that no extensive study has been found in this field so far, this study is aiming to report the studies that have been conducted to determine the efficacy of ozone injection therapy in temporomandibular joint disorders. This report addresses the studies which are conducted clinically, experimentally, and semi-experimentally over the past 10 years (2009-2019). The prepared articles are screened according to the inclusion criteria. In this study, total six related articles are addressed. One study was pre- and postintervention, and five studies were clinical trials. Studies show that although more studies are needed in contrast with occlusal splint, ozone therapy is generally more effective treatment for pain reduction compared to medication. Copyright:Entities:
Keywords: Ozone therapy; jaw; temporomandibular joint disorders
Year: 2020 PMID: 33816392 PMCID: PMC8012860 DOI: 10.4103/abr.abr_105_20
Source DB: PubMed Journal: Adv Biomed Res ISSN: 2277-9175
Ozone injection therapy in temporomandibular disorders
| Final findings | Sample size | Study method | Title | Year | Author |
|---|---|---|---|---|---|
| Injecting intra-articular ozone gas is a promising treatment method for managing the internal contraction of the temporomandibular joint. However, more clinical and experimental studies are needed to provide direct evidence for mechanism of its performance and to prove the results | 60 patients | Clinical trials | Role of intra-articular ozone gas injection in the management of internal derangement of the temporomandibular joint | 2012 | Daif[ |
| 29% of patients in the ozone therapy group and 24% of patients in the drug group experienced a gradual decrease in pain which the difference between the two groups was significant | 63 patients | Clinical trials | Effects of high-frequency bio-oxidative ozone therapy in temporomandibular disorder-related pain | 2014 | Doğan |
| Patients of the ozone therapy group showed a significant decrease in the pain score compared to the control group | 57 patients | Clinical trials | Ozone therapy as an alternative treatment to the pain in the temporomandibular disorder | 2016 | Reyes and Alghannam[ |
| Clinical efficacy of arthrocentesis with ozone in the temporomandibular joint internal derangements. Efficacy of ozonized water as a clinically applicable form of ozone in ozone therapy for the temporomandibular joint | 30 patients | Clinical trial | Use of Ozone in Temporomandibular Joint Arthrocentesis, Clinical Study | 2013 | Hammuda |
| Movements of mandible had a significant difference for the time factor in both ozone therapy and occlusal splint groups. Muscle pain and pressure threshold was significantly higher in the occlusal splint group. Both treatments statistically reduced Visual Analog Scale scores. However, statistically, there was no significant difference between the groups | 40 patients | Clinical trials | Management of pain in TMD patients: Bio-oxidative ozone therapy versus occlusal splints | 2019 | Celakil |
| The use of high-frequency ozone therapy can be a good alternative for managing pain and jaw movements in patients with temporomandibular disorder | 40 patients | Interventional | Evaluation of the Short-Term Efficacy of Transdermal Ozone Therapy in Turkish Patients with Internal Derangement of the Temporomandibular Joint | 2019 | Özalp |
The dosage of the ozone for ozone therapy of the temporomandibular joint in different studies
| Dosage | Treatment period | Explanation | |
|---|---|---|---|
| 18 | 30% concentration | 3 times per week for 10 min | |
| 19 | 10-100 μg/ml, 60% ozone intensity | 3 treatment sessions per week for 10 min, for 2 weeks; total 6 sessions | |
| 20 | 80% ozone intensity | 10 min bilaterally, three times for a week | |
| 21 | 10 sections 3 mg/L for a volume of 3 ml equivalent to 0.03 mg in one bilateral section | 10 sessions | Totally 3 mg |
| 22 | 2 mL ozone-oxygen mixture (ozone gas concentration 10 µg/mL) | 2 times per week for 3 weeks | Totally 120 µg |
| 23 | 70 μg /ml | 200 ml totally | Totally 14 mg |